Kevin Charles Gorman, Director at NEUROCRINE BIOSCIENCES INC (NBIX), sold 4,548 shares at $118.37 ($538K) on 2025-02-10, disclosed to the SEC on 2025-02-12.
Scheduled sale ($538k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $118.37 | 2,274 | $269K | 50.0% |
| 2 | $118.37 | 2,274 | $269K | 50.0% |
| Total | $118.37 avg | 4,548 | $538K | 100% |
| Filing → |
| NBIX | SELL | 2025-08-11 | $26.9M | — | Filing → |
| XNCR | SELL | 2025-06-16 | $29K | — | Filing → |
| NBIX | SELL | 2025-05-29 | $2.3M | — | Filing → |